ID NZM009 AC CVCL_D847 SY NZM09; NZM9 DR BioSample; SAMN14558319 DR Cosmic; 2007649 DR Cosmic; 2141930 DR Wikidata; Q54931632 RX CelloPub=CLPUB00227; RX PubMed=11216673; RX PubMed=20041153; RX PubMed=23658559; RX PubMed=23755070; RX PubMed=24455489; RX PubMed=32567790; CC Doubling time: 45.6 hours (CelloPub=CLPUB00227). CC Omics: Genomics; Whole exome sequencing. CC Omics: Transcriptomics; Microarray. CC Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097. ST Source(s): PubMed=32567790 ST Amelogenin: X,Y ST CSF1PO: 11,12 ST D13S317: 11,12 ST D16S539: 11 ST D18S51: 12.3 ST D19S433: 12,14 ST D21S11: 29.3,30 ST D2S1338: 24 ST D3S1358: 15,16 ST D5S818: 11,13 ST D7S820: 10 ST D8S1179: 11,17 ST FGA: 21,23 ST TH01: 7,9 ST TPOX: 8 ST vWA: 15,21,22 DI NCIt; C3224; Melanoma OX NCBI_TaxID=9606; ! Homo sapiens (Human) SX Male AG 80Y CA Cancer cell line DT Created: 22-10-12; Last updated: 10-04-25; Version: 14 // RX PubMed=20041153; DOI=10.1371/journal.pone.0008461; PMCID=PMC2794539; RA Jeffs, Aaron R. RA Glover, Amy C. RA Slobbe, Lynn J. RA Wang, Li RA He, Shu-Jie RA Hazlett, Jody A. RA Awasthi, Anshul RA Woolley, Adele G. RA Marshall, Elaine S. RA Joseph, Wayne R. RA Print, Cristin Gregor RA Baguley, Bruce Charles RA Eccles, Michael R. RT "A gene expression signature of invasive potential in metastatic RT melanoma cells."; RL PLoS ONE 4:e8461.1-e8461.11(2009). // RX PubMed=24455489; DOI=10.3389/fonc.2013.00333; PMCID=PMC3888952; RA D'mello, Stacey Ann N. RA Flanagan, Jack U. RA Green, Taryn N. RA Leung, Euphemia Yee RA Askarian-Amiri, Marjan E. RA Joseph, Wayne R. RA McCrystal, Michael R. RA Isaacs, Richard J. RA Shaw, James H.F. RA Furneaux, Christopher E. RA During, Matthew John RA Finlay, Graeme John RA Baguley, Bruce Charles RA Kalev-Zylinska, Maggie Lucy RT "Evidence that GRIN2A mutations in melanoma correlate with decreased RT survival."; RL Front. Oncol. 3:333.1-333.9(2014). // RX PubMed=32567790; DOI=10.1111/pcmr.12908; PMCID=PMC7818249; RA Tran, Khanh B. RA Gimenez, Gregory RA Tsai, Peter RA Kolekar, Sharada RA Rodger, Euan J. RA Chatterjee, Aniruddha RA Jabed, Anower RA Shih, Jen-Hsing RA Joseph, Wayne R. RA Marshall, Elaine S. RA Wang, Qian RA Print, Cristin Gregor RA Eccles, Michael R. RA Baguley, Bruce Charles RA Shepherd, Peter R. RT "Genomic and signalling pathway characterization of the NZM panel of RT melanoma cell lines: a valuable model for studying the impact of RT genetic diversity in melanoma."; RL Pigment Cell Melanoma Res. 34:136-143(2021). // RX CelloPub=CLPUB00227; RA Daukste, Liene RT "Mathematical modelling of cancer cell population dynamics."; RL Thesis PhD (2012); University of Canterbury; Christchurch; New Zealand. // RX PubMed=23755070; DOI=10.3389/fgene.2013.00097; PMCID=PMC3668138; RA Kim, Ji Eun RA Leung, Euphemia Yee RA Baguley, Bruce Charles RA Finlay, Graeme John RT "Heterogeneity of expression of epithelial-mesenchymal transition RT markers in melanocytes and melanoma cell lines."; RL Front. Genet. 4:97.1-97.8(2013). // RX PubMed=23658559; DOI=10.3389/fgene.2013.00066; PMCID=PMC3647113; RA Stones, Clare J. RA Kim, Ji Eun RA Joseph, Wayne R. RA Leung, Euphemia Yee RA Marshall, Elaine S. RA Finlay, Graeme John RA Shelling, Andrew N. RA Baguley, Bruce Charles RT "Comparison of responses of human melanoma cell lines to MEK and BRAF RT inhibitors."; RL Front. Genet. 4:66.1-66.6(2013). // RX PubMed=11216673; DOI=10.3727/096504001108747620; RA Parmar, Jayamala RA Marshall, Elaine S. RA Charters, Geoffrey A. RA Holdaway, Karen M. RA Shelling, Andrew N. RA Baguley, Bruce Charles RT "Radiation-induced cell cycle delays and p53 status of early passage RT melanoma cell lines."; RL Oncol. Res. 12:149-155(2000). //